Senior Leadership

The Senior Leadership at Genmab comprises our CEO, a scientist with a deep understanding of the antibody field and proven business acumen, our CFO, who has more than 25 years of finance experience in the life sciences sector, our CDO, with more than 10 years of experience in R&D leadership roles in big pharma and six Senior Vice Presidents.  

JWI 190x126 Jan G. J. van de Winkel, Ph.D.

Dutch
President & Chief Executive Officer

DAE 190x126David A. Eatwell

British (USA citizenship)
Executive Vice President & Chief Financial Officer

JKY 190x126Judith Klimovsky, MD

American
Executive Vice President & Chief Development Officer  

MKB 190x126Michael K. Bauer, Ph.D.

German
Senior Vice President, Clinical Development

BST 190x126Birgitte Stephensen, M.Sc.

Danish
Senior Vice President, IPR & Legal

TAI 190x126Tahamtan Ahmadi, M.D., Ph.D.

Iranian-German (US Citizen)
Senior Vice President Oncology and Translational Medicine

RCG 190x126Rachel Curtis Gravesen

British
Senior Vice President, Investor Relations and Communications

APA 190x126Anthony Pagano

American
Senior Vice President, Global Finance

MVU 190x126Martine J. van Vugt, Ph.D.

Dutch
Senior Vice President Strategic Initiatives